A Meta-Analysis of C-Reactive Protein in Patients With Alzheimer’s Disease
暂无分享,去创建一个
Wei Zhang | Ying Wang | Wei Zhang | Guohua Yu | Guohua Yu | Changguo Gong | Daixin Wei | Ji Ma | Chonggang Yuan | Yulan Zhao | Yulan Zhao | Chonggang Yuan | Ying Wang | Changguo Gong | Ji Ma | Dai Wei
[1] S. Ogawa,et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. , 1997, Circulation.
[2] M. Cesari,et al. Proinflammatory cytokines, aging, and age-related diseases. , 2013, Journal of the American Medical Directors Association.
[3] L. Gustafson,et al. C-reactive protein level is decreased in patients with Alzheimer's disease and related to cognitive function and survival time. , 2011, Clinical biochemistry.
[4] W. M. van der Flier,et al. Evaluation of intrathecal serum amyloid P (SAP) and C-reactive protein (CRP) synthesis in Alzheimer's disease with the use of index values. , 2011, Journal of Alzheimer's disease : JAD.
[5] S. Ferreira,et al. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease , 2014, Alzheimer's & Dementia.
[6] A. Parry-Jones,et al. C-Reactive Protein Predicts Hematoma Growth in Intracerebral Hemorrhage , 2014, Stroke.
[7] J. Olshaker,et al. The C-reactive protein. , 1999, The Journal of emergency medicine.
[8] T. Duong,et al. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease , 1997, Brain Research.
[9] A. Alajbegović,et al. Elevated serum C-reactive protein concentration in Bosnian patients with probable Alzheimer's disease. , 2007, Journal of Alzheimer's disease : JAD.
[10] P. Mcgeer,et al. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer’s disease , 2000, Brain Research.
[11] J. Ramchandani,et al. Potential biomarkers for dementia in Trinidad and Tobago , 2007, Neuroscience Letters.
[12] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[13] H. Braak,et al. Evolution of neuronal changes in the course of Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.
[14] P. Bossuyt,et al. BMC Medical Research Methodology , 2002 .
[15] William T. Hu,et al. Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease , 2013, Journal of the Neurological Sciences.
[16] H. Soares,et al. The link between C-reactive protein and Alzheimer's disease among Mexican Americans. , 2013, Journal of Alzheimer's disease : JAD.
[17] Wei Zhang,et al. Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis. , 2013, Journal of nephrology.
[18] D. Mungas. In-office mental status testing: a practical guide. , 1991, Geriatrics.
[19] E. Sofić,et al. Elevated serum homocysteine level is not associated with serum C-reactive protein in patients with probable Alzheimer’s disease , 2009, Journal of Neural Transmission.
[20] P. Gorelick. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials , 2010, Annals of the New York Academy of Sciences.
[21] G. Davı̀,et al. Determinants of platelet activation in Alzheimer's disease , 2007, Neurobiology of Aging.
[22] C. Jack,et al. Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative , 2012, Alzheimer's & Dementia.
[23] P. Scheltens,et al. Inflammatory markers in AD and MCI patients with different biomarker profiles , 2009, Neurobiology of Aging.
[24] Xin Lu,et al. Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis , 2011, Journal of Cancer Research and Clinical Oncology.
[25] R. Veerhuis,et al. Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease , 2010, Neurodegenerative Diseases.
[26] Heng Zhou,et al. Promotion of β-amyloid production by C-reactive protein and its implications in the early pathogenesis of Alzheimer’s disease , 2012, Neurochemistry International.
[27] N. Herrmann,et al. A Meta-Analysis of Cytokines in Alzheimer's Disease , 2010, Biological Psychiatry.
[28] R. Green,et al. Extended results of the Alzheimer’s disease anti-inflammatory prevention trial , 2011, Alzheimer's & Dementia.
[29] H. Arai,et al. Increased protein-conjugated acrolein and amyloid-β40/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[30] Han-Ting Zhang,et al. Memory deficits and neurochemical changes induced by C-reactive protein in rats: implication in Alzheimer’s disease , 2009, Psychopharmacology.
[31] H. Arai,et al. Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections , 1994, Neuroscience Letters.
[32] Q. Sun,et al. Prognostic Role of C-Reactive Protein in Breast Cancer: A Systematic Review and Meta-Analysis , 2011, The International journal of biological markers.
[33] D. Blacker,et al. The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.
[34] D. Coakley,et al. Acute phase reactants in Alzheimer's disease , 1996, Biological Psychiatry.
[35] Eric J Topol,et al. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins , 2004, The Lancet.
[36] S. Waring,et al. Decreased C-Reactive Protein Levels in Alzheimer Disease , 2010, Journal of geriatric psychiatry and neurology.
[37] R. Schmidt,et al. Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study , 2002, Annals of neurology.